- Home
- DEVS vs ICCM Comparison
DEVS vs ICCM Comparison
Compare DEVS & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEVS
- ICCM
- Stock Information
- Founded
- DEVS N/A
- ICCM 2006
- Country
- DEVS Canada
- ICCM Israel
- Employees
- DEVS N/A
- ICCM N/A
- Industry
- DEVS
- ICCM
- Sector
- DEVS
- ICCM
- Exchange
- DEVS NYSE
- ICCM Nasdaq
- Market Cap
- DEVS 16.5M
- ICCM 45.5M
- IPO Year
- DEVS N/A
- ICCM N/A
- Fundamental
- Price
- DEVS $0.81
- ICCM $1.12
- Analyst Decision
- DEVS
- ICCM Strong Buy
- Analyst Count
- DEVS 0
- ICCM 2
- Target Price
- DEVS N/A
- ICCM $2.70
- AVG Volume (30 Days)
- DEVS 5.0M
- ICCM 429.1K
- Earning Date
- DEVS 02-12-2025
- ICCM 11-26-2024
- Dividend Yield
- DEVS N/A
- ICCM N/A
- EPS Growth
- DEVS N/A
- ICCM N/A
- EPS
- DEVS N/A
- ICCM N/A
- Revenue
- DEVS N/A
- ICCM $3,671,000.00
- Revenue This Year
- DEVS N/A
- ICCM $10.03
- Revenue Next Year
- DEVS N/A
- ICCM $62.68
- P/E Ratio
- DEVS N/A
- ICCM N/A
- Revenue Growth
- DEVS N/A
- ICCM 26.02
- 52 Week Low
- DEVS $0.48
- ICCM $0.48
- 52 Week High
- DEVS $1.91
- ICCM $1.57
- Technical
- Relative Strength Index (RSI)
- DEVS N/A
- ICCM 74.19
- Support Level
- DEVS N/A
- ICCM $1.04
- Resistance Level
- DEVS N/A
- ICCM $1.12
- Average True Range (ATR)
- DEVS 0.00
- ICCM 0.08
- MACD
- DEVS 0.00
- ICCM 0.01
- Stochastic Oscillator
- DEVS 0.00
- ICCM 82.50
About DEVS DEVVSTREAM CORP
DevvStream Corp is a technology based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve their sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.